ropn1l Antibody

Shipped with Ice Packs
In Stock

Description

Introduction

ROPN1L (Ropporin-1-like) is a protein critical for sperm motility and fibrous sheath (FS) integrity, a cytoskeletal structure in sperm flagella. The ROPN1L antibody is a research tool used to detect and study this protein, often employed in immunohistochemistry (IHC), Western blot (WB), and immunoprecipitation (IP) assays. Its applications span reproductive biology and oncology, with emerging roles in targeted cancer therapies.

Key Features of ROPN1L Antibody

  • Target: ROPN1L (26 kDa), localized to the fibrous sheath of sperm and expressed in testis/epididymis .

  • Applications: WB, IHC, IP, and ELISA .

  • Specificity: Validated for human, mouse, and rat samples .

Molecular Characterization of ROPN1L

ROPN1L is encoded by the ROPN1L gene (GenBank ID: BC014607), located on human chromosome 5p15.2 . The protein contains a conserved N-terminal AKAP-binding domain and a cysteine-rich Fz domain, enabling interactions with A-kinase anchoring proteins (AKAPs) and PKA signaling pathways .

Protein Structure and Gene Information

FeatureDetails
Molecular Weight26 kDa (calculated), 26 kDa (observed)
Subcellular LocationFibrous sheath of sperm flagella
Gene ExpressionTissue-enriched (testis, epididymis)
OrthologsConserved in mice, rats, and fish

Antibody Applications and Validation

ROPN1L antibodies are used to study sperm motility defects and fibrous sheath integrity. Key applications include:

3.1. Western Blot (WB)

  • Reactivity: Human, mouse, rat .

  • Dilution: 1:500–1:2000 .

  • Observed Bands: 26 kDa (expected), confirmed via IP in human testis lysate .

3.2. Immunohistochemistry (IHC)

  • Staining: Mouse testis and human colon cancer tissue .

  • Antigen Retrieval: Citrate buffer (pH 6) or TE buffer (pH 9) .

3.3. Immunoprecipitation (IP)

  • Target Validation: ROPN1L interacts with AKAP3 and FSCB (Fibrous Sheath CABYR Binding Protein) .

4.1. Sperm Motility and Fibrous Sheath Integrity

  • ROPN1L Knockout (RLKO) Mice: Reduced sperm motility and PKA-dependent signaling defects .

  • Double Knockout (DKO): Complete immotility due to fibrous sheath thinning and AKAP3 loss .

4.2. Phosphorylation and SUMOylation

  • FSCB Phosphorylation: Inhibits ROPN1L SUMOylation, enhancing sperm capacitation .

  • PKA Signaling: ROPN1L stabilizes AKAP3, a scaffold for PKA and tyrosine kinases .

4.3. Oncological Relevance

  • Triple-Negative Breast Cancer (TNBC): ROPN1 (a paralog of ROPN1L) is a tumor-specific antigen, targeted by engineered T-cell receptors .

  • Expression: ROPN1L is absent in healthy tissues (except testis/epididymis), minimizing on-target toxicity .

Product Specs

Buffer
Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M PBS, pH 7.4
Form
Liquid
Lead Time
Made-to-order (14-16 weeks)
Synonyms
ropn1l antibody; si:rp71-1f1.7 antibody; Ropporin-1-like protein antibody
Target Names
ropn1l
Uniprot No.

Target Background

Function
The ropn1l antibody is crucial for male fertility. ROPN1, a protein involved in the ropn1l antibody, plays a critical role in fibrous sheath integrity and sperm motility. Furthermore, it participates in PKA-dependent signaling processes essential for spermatozoa capacitation.
Database Links
Protein Families
Ropporin family
Subcellular Location
Cell projection, cilium, flagellum. Cell projection, cilium.

Q&A

What is ROPN1L and what is its biological significance?

ROPN1L is a protein-coding gene and a member of the ropporin family that plays a crucial role in sperm function. Its biological significance lies primarily in male reproductive biology, where mutations in ROPN1L can cause defects in fibrous sheath integrity, sperm motility, and PKA-dependent signaling processes, ultimately leading to male infertility . The protein has a calculated molecular weight of approximately 26 kDa and consists of 230 amino acids . In mammals, ROPN1L has been investigated for its involvement in the cAMP-dependent protein kinase pathway and its interactions with A-kinase anchor proteins that affect sperm motility .

What are the typical applications for ROPN1L antibodies in research?

ROPN1L antibodies can be utilized in multiple experimental applications, with varying recommended dilutions depending on the specific technique:

ApplicationCommon Dilution RangeSample Types
Western Blotting (WB)1:500-1:2000Mouse testis tissue, rat testis tissue
Immunohistochemistry (IHC)1:50-1:500Mouse testis tissue, human colon cancer tissue
Enzyme-Linked Immunosorbent Assay (ELISA)Varies by antibodySerum samples, protein extracts

The optimal dilution should be determined experimentally for each specific application and antibody . For immunohistochemistry, antigen retrieval with TE buffer pH 9.0 is often suggested, though citrate buffer pH 6.0 may also be used as an alternative .

How should researchers select the appropriate ROPN1L antibody for their experiments?

The selection process should consider several factors:

  • Target epitope location: Different antibodies target different regions of ROPN1L. Some target the N-terminal region (e.g., AA 39-68), while others target the C-terminal region . The epitope location can significantly impact antibody performance depending on protein folding, post-translational modifications, or protein-protein interactions in your experimental context.

  • Host species: Most commercial ROPN1L antibodies are rabbit polyclonals, which influences secondary antibody selection and potential cross-reactivity concerns in multi-labeling experiments .

  • Validated applications: Verify that the antibody has been validated for your specific application (WB, IHC, ELISA) .

  • Species reactivity: Confirm that the antibody has been tested and shows reactivity with your species of interest. Available antibodies demonstrate reactivity with human, mouse, and rat samples .

What controls should be included when using ROPN1L antibodies?

A robust experimental design with appropriate controls is essential for generating reliable data:

  • Positive tissue controls: Mouse or rat testis tissue serves as an excellent positive control due to high ROPN1L expression .

  • Negative controls:

    • Primary antibody omission control

    • Isotype control (rabbit IgG at the same concentration)

    • Tissues known to lack ROPN1L expression

  • Blocking peptide control: If available, pre-incubate the antibody with the immunizing peptide before applying to samples to confirm specificity.

  • Genetic controls: When possible, compare results between wild-type and ROPN1L-knockout tissues or cells.

How can researchers optimize ROPN1L antibody detection in Western blotting?

Optimization strategies for Western blotting with ROPN1L antibodies include:

  • Sample preparation: For optimal protein extraction from sperm-rich tissues:

    • Use RIPA buffer supplemented with protease inhibitors

    • Include brief sonication steps to disrupt fibrous structures

    • Consider specialized extraction protocols for sperm proteins

  • Gel percentage: Use 12-15% polyacrylamide gels for optimal resolution of the 26 kDa ROPN1L protein .

  • Transfer parameters:

    • Transfer time: 1 hour at 100V or overnight at 30V

    • Transfer buffer: Consider adding 10-20% methanol to enhance transfer of lower molecular weight proteins

  • Blocking conditions:

    • Use 5% non-fat dry milk or 3-5% BSA in TBST

    • Block for 1-2 hours at room temperature

  • Primary antibody incubation: Start with 1:1000 dilution in blocking buffer, incubate overnight at 4°C .

What are the critical considerations for immunohistochemical detection of ROPN1L?

For optimal immunohistochemical detection of ROPN1L:

  • Fixation: 4% paraformaldehyde or 10% neutral buffered formalin for 24-48 hours.

  • Antigen retrieval: TE buffer pH 9.0 is recommended, though citrate buffer pH 6.0 can be used as an alternative . Heat-induced epitope retrieval (pressure cooker or microwave) is typically more effective than enzymatic retrieval methods.

  • Blocking endogenous peroxidase: 3% hydrogen peroxide for 10 minutes if using HRP-based detection systems.

  • Antibody dilution: Begin with 1:100 dilution and optimize based on signal-to-noise ratio .

  • Detection system: Polymer-based detection systems often provide better sensitivity than avidin-biotin complex methods for detecting ROPN1L.

  • Visualization: DAB (3,3'-Diaminobenzidine) for brightfield or appropriate fluorophore-conjugated secondary antibodies for fluorescence microscopy.

How can ROPN1L antibodies be used to investigate male infertility?

ROPN1L antibodies can be valuable tools for investigating male infertility through several methodological approaches:

  • Comparative expression analysis: Compare ROPN1L protein levels in sperm samples from fertile and infertile men using Western blotting with densitometric analysis.

  • Localization studies: Use immunofluorescence to assess proper localization of ROPN1L in the sperm flagellum, as mislocalization could indicate structural abnormalities.

  • Co-immunoprecipitation: Use ROPN1L antibodies to pull down protein complexes and identify altered interactions with PKA or A-kinase anchoring proteins that may contribute to motility defects .

  • Phosphorylation status: Combine ROPN1L antibodies with phospho-specific antibodies to evaluate whether PKA-dependent phosphorylation of sperm proteins is altered in infertility cases.

  • Tissue microarrays: Analyze ROPN1L expression patterns across testicular biopsies from patients with different infertility diagnoses.

What is the role of ROPN1L in parasitic infection research, and how are antibodies used?

ROPN1L has emerging importance in parasitic infection research, particularly in opisthorchiasis:

The Opisthorchis viverrini ROPN1L (OvROPN1L) protein has shown potential as a diagnostic antigen for human opisthorchiasis . Researchers have identified that the N-terminal region, specifically a peptide fragment comprising amino acids L3-Q13 (LVNDPYYCHEQ), demonstrated the highest antigenicity and specificity for detecting O. viverrini infection .

Methodological approaches for using ROPN1L in parasite research include:

  • Recombinant protein production: Express fragments of ROPN1L (like H1 comprising codons 1-111) as fusion proteins for antibody development and diagnostic assays .

  • Epitope mapping: Use synthetic peptides covering different regions of ROPN1L to identify immunodominant epitopes with highest diagnostic potential .

  • Cross-reactivity testing: Evaluate antibody responses against ROPN1L epitopes using sera from patients with various helminth infections to determine specificity .

  • ELISA development: Use purified recombinant ROPN1L or synthetic peptides as coating antigens for developing diagnostic ELISAs .

How can researchers differentiate between ROPN1L and other ropporin family members?

Differentiating between ROPN1L and other ropporin family members requires careful antibody selection and experimental design:

  • Epitope selection: Choose antibodies targeting unique regions that don't share sequence homology with other ropporin family members. The N-terminal region often shows greater sequence divergence .

  • Antibody validation: Perform specificity testing using:

    • Overexpression systems with each ropporin family member

    • Peptide competition assays with specific peptides from different ropporin proteins

    • Western blotting against recombinant proteins of each family member

  • Knockout/knockdown controls: When available, use genetic models where specific ropporin family members have been depleted.

  • Mass spectrometry verification: For critical experiments, confirm antibody specificity through immunoprecipitation followed by mass spectrometry analysis.

What are common technical issues when using ROPN1L antibodies, and how can they be resolved?

IssuePotential CausesSolutions
Weak or no signal in Western blotInadequate protein extraction, low expression levels, poor transferUse specialized extraction buffers for reproductive tissues; increase protein loading; optimize transfer parameters for 26 kDa proteins
High background in IHCInsufficient blocking, antibody concentration too highIncrease blocking time (2-3 hours); optimize antibody dilution; add 0.1-0.3% Triton X-100 to reduce non-specific binding
Multiple bands in Western blotCross-reactivity, protein degradation, post-translational modificationsUse fresh samples with protease inhibitors; validate with peptide competition; consider using monoclonal antibodies if available
Variable results between experimentsInconsistent sample preparation, protocol variationsStandardize tissue collection and processing; document and control incubation times and temperatures

How should researchers store and handle ROPN1L antibodies to maintain optimal performance?

Proper storage and handling are critical for antibody performance:

  • Long-term storage: Store at -20°C in small aliquots to avoid repeated freeze-thaw cycles. Antibodies containing 50% glycerol are stable for one year after shipment when stored properly .

  • Working solution preparation: Dilute only the amount needed for immediate use.

  • Buffer considerations: Many ROPN1L antibodies are stored in PBS with 0.02% sodium azide and 50% glycerol at pH 7.3 .

  • Freeze-thaw cycles: Minimize repeated freezing and thawing, which can lead to antibody degradation and loss of activity.

  • Temperature transitions: Allow antibody aliquots to completely thaw and equilibrate to room temperature before opening to prevent condensation.

  • Contamination prevention: Use sterile technique when handling antibody solutions.

How can researchers validate the specificity of ROPN1L antibodies for their experimental system?

Validation of antibody specificity is critical for reliable results:

  • Western blot analysis: Confirm that the antibody detects a band of the expected molecular weight (26 kDa for ROPN1L) in tissues known to express the protein (testis) while showing no bands in tissues that don't express ROPN1L.

  • Peptide competition: Pre-incubate the antibody with the immunizing peptide before application to verify that the signal disappears or is significantly reduced.

  • Genetic models: Test the antibody on samples from ROPN1L knockout models or cells with ROPN1L knockdown to confirm absence of signal.

  • Multiple antibodies: Use antibodies targeting different epitopes of ROPN1L and compare staining patterns.

  • Recombinant protein controls: Run purified recombinant ROPN1L alongside your experimental samples as a positive control.

What emerging applications exist for ROPN1L antibodies beyond reproductive biology?

While ROPN1L is primarily studied in reproductive biology, emerging applications include:

  • Parasitology research: The identification of OvROPN1L as a potential diagnostic antigen for opisthorchiasis suggests applications in parasitic disease diagnostics .

  • Cancer research: The detection of ROPN1L in human colon cancer tissue suggests potential roles in cancer biology that warrant further investigation.

  • Comparative biology: Studying ROPN1L across species can provide insights into the evolution of sperm motility mechanisms and reproductive adaptations.

  • Therapeutic target identification: As ROPN1L is involved in cAMP signaling pathways, it may represent a target for developing contraceptives or treatments for specific forms of male infertility.

How might advances in antibody development improve ROPN1L detection and analysis?

Several technological advances could enhance ROPN1L research:

  • Development of monoclonal antibodies: Most current ROPN1L antibodies are polyclonal . Monoclonal antibodies could provide greater specificity and batch-to-batch consistency.

  • Phospho-specific antibodies: Developing antibodies that specifically recognize phosphorylated forms of ROPN1L would help elucidate its regulation in signaling pathways.

  • Nanobodies or single-domain antibodies: These smaller antibody fragments could provide better access to epitopes in densely packed structures like the sperm flagellum.

  • Directly conjugated antibodies: ROPN1L antibodies directly conjugated to fluorophores or enzymes would eliminate secondary antibody steps and potentially reduce background.

  • Improved recombinant antibody technology: This could lead to better characterized antibodies with reduced lot-to-lot variability.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.